Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 1/2000

01-03-2000 | Meeting abstract

Screening for BRCA1 gene mutations by capillary electrophoretic REF-SSCP

Authors: P Kringen, HG Eiken, JC Pedersen, S Egedal, K Berg, KM Tveit, TI Andersen

Published in: Breast Cancer Research | Special Issue 1/2000

Login to get access

Excerpt

The identification of novel mutations in large genes requires efficient mutation-scanning techniques. Except for DNA-sequencing and PTT (protein truncation test), SSCP (single strand conformation polymorphism) is the technique that has been the most extensively applied to scan for mutations in the BRCA1-gene. In the present study a capillary electrophoretic (CE) restriction endonuclease fingerprinting (REF) modification of the SSCP technique was established for BRCA1 exon 11. …
Metadata
Title
Screening for BRCA1 gene mutations by capillary electrophoretic REF-SSCP
Authors
P Kringen
HG Eiken
JC Pedersen
S Egedal
K Berg
KM Tveit
TI Andersen
Publication date
01-03-2000
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 1/2000
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr176

Other articles of this Special Issue 1/2000

Breast Cancer Research 1/2000 Go to the issue

Meeting abstract

Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients

Meeting abstract

Germline TP53mutations in Finnish breast cancer patients

Meeting abstract

Mutational analysis of BRCA1 and BRCA2 genes in Spanish women with early-onset breast cancer

Meeting abstract

Expression of variant forms of the MUC1 gene correlates with the invasiveness of breast cancer cells

Meeting abstract

Clinical and pathological characteristics in patients with BRCA1/2-mutation associated with breast cancer (BC) with a long clinical follow-up

Meeting abstract

Phosphorylation of human progesterone receptors by MAPKs mediates transcriptional synergy between progestins and MEKK1 in human breast cancer cells
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits